Powering the Future: From Substrate to System—The Power Module Assembly
Global Sourcing Spotlight: Global Sourcing in the Age of Constant Uncertainty 
Nolan’s Notes: The CMMC Certification Question Mark
Nordson Corporation reported results for the fiscal third quarter ended July 31, 2026. Sales were a quarterly record of $818 million, an increase of 10% compared to the prior year’s third quarter sales of $742 million. The third quarter 2026 sales included an organic sales increase of approximately 12% driven by growth in all segments. Organic sales growth was partially offset by the net unfavorable impact of a prior year divestiture and an acquisition in the second quarter.
Net income was $153 million, or a record $2.73 of earnings per diluted share, compared to prior year’s third quarter net income of $126 million, or $2.22 of earnings per diluted share. Third quarter 2026 earnings included a non-cash loss on a minority investment recognized during the quarter. Excluding this item and acquisition-related amortization and costs, third quarter adjusted earnings per diluted share were a record $3.25, a 19% increase from the prior year adjusted earnings per diluted share of $2.73.
Third quarter EBITDA reached an all-time quarterly record of $262 million, or 32% of sales, an increase of 10% compared to prior year EBITDA of $239 million, also at 32% of sales.
Commenting on the Company’s fiscal 2026 third quarter results, Nordson President and Chief Executive Officer Sundaram Nagarajan said, “The strong momentum of the first half continued through the third quarter, delivering results above the high-end of our most recent earnings guidance. The team’s strong execution of the Ascend Strategy, combined with our diversified portfolio, differentiated precision technology and operational excellence, positioned us to deliver record sales in all three segments while maintaining our best-in-class margin performance. In addition, strong free cash flow generation enabled us to further strengthen our balance sheet, return capital to shareholders, and continue investing in the business to support future growth. I want to thank our global employees for delivering on the needs of our customers and achieving another outstanding quarter.”
Third Quarter Segment Results
Record third quarter Industrial Precision Solutions sales of $367 million increased 5% from the prior year, inclusive of an organic sales increase of 3%, favorable currency translation of 1%, and an acquisition contribution of 1%. The organic sales increase was driven by strength in packaging, industrial coatings, polymer processing and nonwovens product lines. EBITDA in the quarter was $130 million, or 35% of sales, in line with prior year third quarter EBITDA of $130 million.
Medical and Fluid Solutions sales of $231 million, an all-time quarterly record, increased 5% compared to the prior year third quarter. Excluding the divestiture of the contract manufacturing business, organic sales increased 11%. The organic sales increase was driven by growth in engineered fluid solutions and medical product lines related to end market demand. EBITDA in the quarter was also a segment record $88 million, or 38% of sales, up 6% from the prior year third quarter EBITDA of $83 million.
Record quarterly Advanced Technology Solutions sales of $220 million increased 28% compared to the prior year third quarter, inclusive of an organic sales increase of 31% and unfavorable currency translation of 3%. The organic sales increase was driven by strong growth in electronics dispense and test and inspection product lines. EBITDA in the quarter was a segment record $66 million, or 30% of sales, up 58% from the prior year third quarter EBITDA of $42 million.
Outlook
The Company enters the fourth quarter with strong demand momentum and increased backlog, up 35% over the prior year.
Based on the continuing momentum of our end markets as evidenced by our backlog and order entry, the Company is increasing its full year guidance. Sales are now expected to be in the range of $3,035 to $3,075 million and adjusted earnings to be in the range of $11.80 to $12.00 per diluted share.
Reflecting on the full year outlook, Mr. Nagarajan said, “Based on backlog and order entry momentum, we expect the strong sales of the first nine months to continue through the fourth quarter. This puts us on track to achieve over $3 billion in annual revenue for the full year. We are delivering above-market organic growth through accelerating demand in key end markets. Our differentiated technology, close to the customer business model and the execution of the NBS Next growth framework have positioned us well to compound profitable growth this year and into the future.”
